Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q2 FY25
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
126.00 | 145 Cr | 16.18 | 1.52 | 0.00 | 12.38 | 12.15 | 3.93 | ||
29.15 | 138 Cr | 19.18 | 7.78 | 0.00 | 41.95 | 22.81 | 6.97 | ||
103.55 | 136 Cr | 13.24 | 0.97 | 0.77 | 7.69 | 9.73 | 5.99 | ||
153.80 | 135 Cr | 10.37 | 1.90 | 0.00 | 18.31 | 18.42 | 13.68 | ||
82.00 | 134 Cr | 8.95 | 1.39 | 0.00 | 15.51 | 19.06 | 13.51 | ||
61.87 | 130 Cr | 29.79 | 0.70 | 0.00 | 8.06 | 8.98 | 1.68 | ||
100.75 | 127 Cr | 18.28 | 1.96 | 0.00 | 9.36 | 10.75 | 3.79 | ||
| Median: 7 Co. | — | 100.75 | 135 Cr | 16.18 | 1.52 | 0.00 | 12.38 | 12.15 | 5.99 |
Quest Laboratories Ltd (QUESTLAB) is currently trading at 87.30 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Quest Laboratories Limited specializes in the manufacturing of a wide range of pharmaceutical formulations, including ethical and generic drugs. The company is experiencing rapid growth, evidenced by a 52% year-over-year increase in Q1FY26 revenues, thanks to expanded operations and product lines. The development of their USFDA-compliant injectable facility targets both domestic and export markets, showcasing global ambitions in high-demand pharmaceutical segments. Quest Laboratories leverages strategic government partnerships, participating in public sector tenders to secure large-scale orders, aiding its growth and market stability. Its commitment to R&D and expanding manufacturing capabilities, including new investments in advanced injectables and capsules, positions the company for continued innovation and market penetration.
Over the past 52 weeks, Quest Laboratories Ltd has traded between a low of ₹81.30 and a high of ₹152.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Quest Laboratories Ltd has a market capitalization of approximately 134.38. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Quest Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 8.95 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 134.38 Cr, Quest Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Quest Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Quest Laboratories Ltd is 8.95. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
3
Neutral
7
Bullish
4
Bearish
18
Neutral
7
Bullish
21
Bearish
15
Neutral
0
Bullish
17
Bearish
3
Neutral
7
Bullish
4
Bearish
3
Neutral
7
Bullish
4
Bearish
15
Neutral
0
Bullish
17
Bearish
15
Neutral
0
Bullish
17
Bearish
15
Neutral
0
Bullish
17
Quest Laboratories Limited specializes in the manufacturing of a wide range of pharmaceutical formulations, including ethical and generic drugs.
The company is experiencing rapid growth, evidenced by a 52% year-over-year increase in Q1FY26 revenues, thanks to expanded operations and product lines.
The development of their USFDA-compliant injectable facility targets both domestic and export markets, showcasing global ambitions in high-demand pharmaceutical segments.
Quest Laboratories leverages strategic government partnerships, participating in public sector tenders to secure large-scale orders, aiding its growth and market stability.
Its commitment to R&D and expanding manufacturing capabilities, including new investments in advanced injectables and capsules, positions the company for continued innovation and market penetration.
Pharmaceuticals & Biotechnology
Pharmaceuticals
134 Cr
Low Risk
9.0
37.7
0.2
1.4
152.60
81.30
Sales CAGR
Profit CAGR
ROE
ROCE
